HealthStream, Inc.HSTMNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+96.5%
5Y CAGR+23.6%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+96.5%/yr
Quarterly compound
5Y CAGR
+23.6%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
2.9x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 21.89% |
| Q3 2025 | 0.28% |
| Q2 2025 | 0.22% |
| Q1 2025 | -5.01% |
| Q4 2024 | 4.81% |
| Q3 2024 | 0.20% |
| Q2 2024 | 0.37% |
| Q1 2024 | 0.85% |
| Q4 2023 | 9.44% |
| Q3 2023 | -1.18% |
| Q2 2023 | -5.56% |
| Q1 2023 | -1.08% |
| Q4 2022 | 2.88% |
| Q3 2022 | 8.44% |
| Q2 2022 | 1.64% |
| Q1 2022 | -9.10% |
| Q4 2021 | 10.73% |
| Q3 2021 | 0.08% |
| Q2 2021 | 8.51% |
| Q1 2021 | 8.07% |
| Q4 2020 | 7.59% |
| Q3 2020 | 4.62% |
| Q2 2020 | 4.85% |
| Q1 2020 | 1.66% |
| Q4 2019 | 2.10% |
| Q3 2019 | -5.82% |
| Q2 2019 | 10.29% |
| Q1 2019 | 5.18% |
| Q4 2018 | -0.21% |
| Q3 2018 | 0.81% |
| Q2 2018 | 9.10% |
| Q1 2018 | -17.46% |
| Q4 2017 | 4.01% |
| Q3 2017 | -0.72% |
| Q2 2017 | 6.70% |
| Q1 2017 | -10.50% |
| Q4 2016 | 1.54% |
| Q3 2016 | 0.23% |
| Q2 2016 | 3.22% |
| Q1 2016 | -7.16% |